You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Hensley Mark Earl · SEC Form 4 · Filed Nov 10, 2026
Exercise
Reported value range
Not reported
Hensley Mark Earl Chief Operating Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Nov 6, 2026
Public filing date
Nov 10, 2026
Filing lag
Filed 4 days later
HRTX daily price context
Close on/before transaction
$0.29
Nov 6, 2026
First close after public filing
$0.37
Nov 10, 2026
Return after filing · so far
-10.84%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 31,250 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-454742
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.58K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Nov 6, 2026 | $0 |
| Heron Therapeutics, Inc. /de/ HRTX Current | Exercise | Nov 6, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Nov 6, 2026 | $2.58K |